use
sever
recombin
vaccinia
express
system
pioneer
bernard
moss
colleagu
focu
system
use
cell
biologist
discuss
advantag
limit
vacciniamedi
express
use
assess
cellular
local
posttransl
modif
oligomer
transport
turnov
rate
system
provid
rapid
method
screen
mutant
protein
express
target
excel
way
quickli
decid
mutant
protein
might
worth
studi
use
stabl
express
system
use
vaccinia
vector
discuss
includ
method
largescal
product
protein
detail
method
largescal
product
protein
cdna
vaccinia
method
discuss
see
earl
moss
moss
er
al
moss
vaccinia
viru
beststudi
member
poxvirida
largest
complex
anim
virus
widespread
vaccin
vaccinia
viru
probabl
deriv
cowpox
viru
result
worldwid
erad
smallpox
doublestrand
linear
genom
vaccinia
viru
nearli
kb
potenti
gene
goebel
et
al
moss
virion
envelop
approxim
x
nm
size
characterist
brick
shape
fig
sever
featur
vaccinia
life
cycl
make
uniqu
eukaryot
express
vector
least
kb
dna
insert
vaccinia
genom
without
detriment
effect
viral
replic
assembl
vaccinia
replic
complet
within
cytoplasm
host
cell
thu
import
direct
synthesi
polymeras
transcript
factor
addit
viru
wide
host
rang
cultur
mammalian
cell
line
suscept
infect
viru
easi
grow
purifi
larg
quantiti
rel
safe
work
consid
size
vaccinia
viru
complex
replic
assembl
surpris
fig
bind
host
cell
viral
envelop
believ
fuse
directli
plasma
membran
dom
et
al
releas
core
virion
cytoplasm
littl
known
uncoat
step
transcript
earli
gene
begin
within
hr
infect
virion
core
contain
enzym
need
transcript
earli
gene
transcrib
rna
cap
methyl
polyadenyl
cytosol
viral
enzym
dna
replic
begin
hr
occur
discret
juxtanuclear
region
cytosol
term
viral
factori
near
golgi
complex
transcript
intermedi
late
viral
gene
differ
viral
rna
pol
ymeras
viral
assembl
begin
complex
process
appear
involv
two
separ
membran
enwrap
event
result
doubl
lipid
bilay
surround
core
particl
first
doubl
membran
deriv
intermedi
compart
endoplasm
reticulum
er
golgi
sodeik
er
al
viral
dna
insert
crescentshap
region
intermedi
compart
membran
fuse
around
gener
intracellular
matur
viru
imv
formerli
call
intracellular
nake
viru
second
enwrap
membran
deriv
transgolgi
network
schmelz
et
al
plasma
membran
releas
virion
three
membran
extracellular
space
howev
strain
vaccinia
ineffici
releas
cell
approxim
commonli
use
wr
strain
remain
cell
associ
strain
eg
ihdj
produc
substanti
amount
extracellular
viru
sinc
form
intracellular
viru
singli
doubli
enwrap
infecti
viru
usual
purifi
cell
homogen
rather
cultur
medium
express
foreign
gene
use
vaccinia
viru
base
recombin
virus
construct
insert
cdna
nonessenti
thymidin
kinas
tk
gene
direct
indirect
method
express
possibl
fig
foreign
gene
insert
vaccinia
genom
homolog
recombin
use
plasmid
flank
region
vaccinia
dna
ase
use
infect
cell
fuerst
et
al
rna
polymeras
express
effici
cytoplasm
earli
infect
transfect
cell
immedi
infect
vector
contain
gene
interest
clone
behind
promot
result
rapid
effici
express
encod
protein
system
conveni
sinc
recombin
viru
product
unnecessari
commonli
use
vector
pbluescript
stratagen
la
jolla
ca
use
recombin
vaccinia
virus
gener
subclon
foreign
gene
plasmid
transfer
vector
flank
dna
vaccinia
tk
gene
nonessenti
growth
viru
tissu
cultur
plasmid
transfect
vacciniainfect
cell
homolog
recombin
plasmid
vaccinia
genom
gener
recombin
viru
inact
tk
gene
lysat
infect
cell
use
infect
thymidin
kinas
neg
tk
cell
line
usual
human
osteosarcoma
cell
mackett
et
ul
recombin
virus
enrich
grow
cell
presenc
bromodeoxyuridin
brdu
sinc
recombin
virus
tk
mutant
abl
replic
plasmid
transfer
vector
use
recombin
contain
pgalactosidas
gene
see
subsequ
discuss
recombin
virus
distinguish
tk
mutant
color
screen
use
galactosid
xgal
chakrabarti
et
ul
variou
vector
recombin
vaccinia
genom
avail
earl
moss
moss
use
earli
vaccinia
promot
drive
foreign
gene
essenti
cell
biolog
applic
sinc
protein
express
cytopath
effect
viru
infect
becom
evid
vector
use
product
recombin
viru
pscl
iss
fig
deriv
pscl
lss
contain
promot
p
transcrib
earli
late
time
infect
contain
synthet
earlyh
promot
follow
promot
short
polylink
foreign
gene
clone
anoth
vaccinia
promot
p
late
promot
drive
express
bacteri
galactosidas
gene
allow
color
screen
plaqu
help
identifi
recombin
express
cassett
flank
portion
vaccinia
tk
gene
subclon
gene
interest
recombin
vector
sever
thing
must
kept
mind
sinc
splice
subclon
dna
occur
cdna
must
use
untransl
region
kept
short
also
import
check
transcript
termin
sequenc
recogn
earli
rna
polymeras
sequenc
tttttnt
nt
n
nucleotid
caus
termin
transcript
bp
downstream
yuen
moss
thu
silent
mutat
elimin
nt
sequenc
introduc
sitedirect
mutagenesi
prior
subclon
although
protein
still
express
recombin
virus
made
pscl
iss
cdna
contain
nt
sequenc
express
occur
late
phase
viru
infect
pscllss
use
produc
vaccinia
recombin
foreign
gene
start
stop
codon
subclon
stic
sol
site
behind
vaccinia
promot
b
use
polymerasemedi
express
infect
section
plasmid
pbluescript
stratagen
also
use
howev
absenc
polymeras
termin
sequenc
presenc
gc
rich
region
bluescript
polylink
upstream
foreign
gene
reduc
mrna
product
consequ
decreas
protein
express
hr
late
rna
polymeras
termin
transcript
nt
activ
subclon
step
complet
purifi
plasmid
dna
prepar
cscl
gradient
qiagen
method
qiagen
inc
chatsworth
ca
nonpurifi
miniprep
dna
work
ca
po
method
transfect
use
work
vaccinia
viru
perform
standard
biosafeti
level
condit
includ
use
class
biolog
safeti
cabinet
nation
institut
health
nih
center
diseas
control
cdc
guidelin
recommend
worker
vaccin
everi
year
although
institut
set
requir
vaccin
physic
contain
regul
obtain
institut
biosafeti
offic
initi
project
involv
vaccinia
viru
use
class
biolog
safeti
cabinet
autoclav
dispos
item
contact
viru
inactiv
use
solut
contain
infecti
viru
bleach
conveni
way
inactiv
viruscontain
solut
aspir
reservoir
flask
hood
immedi
afterward
use
pasteur
pipet
aspir
bleach
line
addit
precaut
use
larg
quantiti
vaccinia
viru
exampl
grow
purifi
larg
stock
discuss
section
iii
product
recombin
virus
hela
cvi
cell
usual
use
product
recombin
virus
grown
dulbecco
modifi
eagl
medium
dmem
contain
fetal
calf
serum
fc
plate
approxim
x
cell
dish
cell
confluent
next
day
rins
cell
serumfre
dmem
add
ml
serumfre
medium
contain
plaqueform
unit
pfu
cell
wr
strain
vaccinia
viru
use
pfu
total
investig
employ
trypsin
step
prior
infect
requir
viru
stock
cell
lysat
instead
purifi
prepar
add
equal
volum
mgml
trypsin
amount
lysat
requir
incub
min
occasion
vortex
help
dissoci
aggreg
releas
infecti
viru
cell
debri
trypsin
use
dmem
contain
fc
use
dilut
adsorb
viru
fc
inhibit
trypsin
addit
viru
inoculum
cell
return
incub
rock
everi
min
min
hr
trypsin
viru
serumcontain
medium
use
toward
end
infect
period
prepar
ca
po
precipit
dna
transfect
add
pg
dna
pl
x
hepe
buffer
mm
hepe
ph
nacl
sodium
phosphat
add
equal
volum
caci
dropwis
continu
vortex
allow
precipit
form
leav
mixtur
ambient
temperatur
min
precipit
fine
turn
solut
slightli
opaqu
adsorpt
period
remov
viru
inoculum
add
ml
fc
dish
allow
ph
equilibr
co
incub
min
add
precipit
dna
solut
dropwis
gentli
swirl
dish
return
cell
incub
replac
dnacontain
medium
fresh
growth
medium
follow
morn
prepar
cell
lysat
day
infect
scrape
cell
medium
centrifug
min
g
resuspend
cell
pellet
ml
complet
medium
lyse
cell
freez
dri
iceethanol
thaw
three
time
lysat
store
select
screen
perform
prepar
brdu
stock
solut
mgml
water
steril
filter
store
grow
human
cell
dmem
contain
fc
pg
ml
brdu
plate
cell
tissu
cultur
dish
x
cellswel
ml
complet
medium
grow
near
confluenc
usual
overnight
thaw
aliquot
pl
transfect
cell
lysat
add
equal
volum
mgiml
trypsin
incub
mixtur
min
make
serial
dilut
trypsin
lysat
dmem
fc
aspir
medium
cell
infect
cell
well
duplic
ml
dilut
hr
intermitt
rock
toward
end
infect
period
agaros
overlay
prepar
although
viru
remain
cellassoci
overlay
help
insur
plaqu
deriv
singl
virion
melt
previous
autoclav
solut
low
melt
point
agaros
gibcobrl
grand
island
n
water
aliquot
enough
ml
per
well
tube
equilibr
lot
difco
detroit
mi
agar
work
well
toxic
cell
andlor
plaqu
format
warm
concentr
dmem
contain
fc
pgml
brdu
mlwell
end
infect
period
aspir
inoculum
cell
mix
agaros
x
medium
overlay
well
ml
overlay
solidifi
room
temperatur
return
dish
co
incub
day
infect
cell
round
dead
seen
clear
area
plaqu
cell
lawn
see
plaqu
clearli
identifi
recombin
prepar
second
overlay
mix
equal
volum
melt
agaros
x
dmem
contain
mgml
neutral
red
mgml
stock
mgml
xgal
mgml
stock
dimethyl
sulfoxid
dimethyl
formamid
overlay
well
ml
allow
agaros
solidifi
incub
dish
overnight
follow
morn
pick
blue
plaqu
insert
pasteur
pipet
yellow
pipet
tip
agaros
contact
cell
layer
scrape
cell
monolay
gentli
discharg
agaros
plug
steril
microfug
tube
contain
ml
fc
plaqu
isol
vortex
vigor
frozen
thaw
three
time
store
purif
typic
plaqu
pick
taken
two
addit
round
plaqu
purif
describ
subsequ
ascertain
recombin
viru
clonal
deriv
devoid
nonrecombin
viru
round
plaqu
purif
dish
cell
plate
describ
isol
plaqu
frozen
thaw
cell
lysat
dilut
serial
lo
duplic
well
confluent
monolay
infect
ml
dilut
viru
hr
infect
well
overlaid
first
brduagaros
day
second
overlay
contain
xgal
describ
plaquepurifi
recombin
test
sever
differ
method
northern
southern
blot
immunofluoresc
dot
blot
immunoprecipit
insur
contain
gene
interest
insert
vaccinia
tk
gene
commonli
use
immunofluoresc
plaqu
purif
portion
isol
plaqu
use
infect
cell
cover
slip
cell
fix
stain
day
later
see
protocol
section
iv
cell
surround
plaqu
express
foreign
protein
method
screen
plaqu
expand
success
infect
larger
larger
number
cell
usual
done
infect
cell
one
well
dish
half
isol
plaqu
day
cell
lysat
made
describ
use
infect
cell
dish
grow
largescal
prepar
recombin
also
test
express
protein
correct
size
immunoprecipit
radiolabel
infect
cell
follow
electrophoresi
sd
polyacrylamid
gel
see
section
iv
c
l
subclon
recombin
vector
approxim
wk
requir
gener
purifi
vaccinia
recombin
goe
well
cell
success
plaqu
purif
plate
readi
day
plaqu
pick
time
requir
may
somewhat
shorter
recombin
frequenc
rel
high
howev
occasion
blue
mani
clear
plaqu
obtain
one
problem
might
vaccinia
viru
use
infect
cell
recombin
contain
larg
popul
tkviru
solut
plaqu
purifi
wildtyp
vaccinia
test
sever
plaqu
abil
grow
cell
presenc
brdu
select
plaqu
thatfail
grow
ie
tk
futur
use
anoth
problem
might
express
foreign
protein
incompat
vaccinia
replic
assembl
problem
sever
protein
accumul
intermedi
compart
cisgolgi
network
either
recombin
never
obtain
dna
encod
foreign
gene
lost
give
viru
growth
advantag
viru
still
contain
foreign
gene
case
one
altern
use
adoubl
infect
system
moss
el
al
earl
moss
cdna
encod
foreign
gene
clone
recombin
vector
rna
promot
instead
p
promot
ptmi
recombin
viru
produc
describ
alreadi
sinc
protein
express
inteifer
recombin
viru
product
express
mediat
coinfect
cell
anoth
vaccinia
viru
encod
rna
polymeras
altern
infectiontransfect
system
use
section
iv
b
viru
inoculum
crude
cell
lysat
volum
requir
give
pfucel
trypsin
describ
section
ii
c
dilut
medium
serum
infect
rock
infect
cell
everi
min
hr
end
infect
period
add
ml
fc
dish
purifi
viru
day
infect
time
cell
appear
round
remain
attach
dish
although
frozen
thaw
prepar
infect
cell
use
express
work
purifi
viru
stock
recommend
sonic
trypsin
cell
lysat
way
disrupt
viru
aggreg
gener
freez
medium
must
perform
infect
cell
purifi
viru
store
high
ph
buffer
lack
salt
minim
aggreg
thu
trypsin
sonic
unnecessari
infect
purifi
prepar
viru
purif
perform
laminar
flow
hood
glove
worn
pipet
glasswar
use
soak
bleach
autoclav
use
destroy
infecti
viru
scrape
infect
hela
cell
medium
use
rubber
policeman
combin
transfer
dispos
steril
tube
centrifug
min
g
rpm
tabletop
centrifug
resuspend
pellet
total
ml
tri
hcl
ph
homogen
two
batch
ice
dounc
stroke
use
tight
pestl
centrifug
homogen
two
dispos
tube
min
g
remov
nuclei
collect
supernat
save
ice
pellet
wash
resuspend
pellet
small
volum
ph
dilut
ml
solut
recentrifug
step
transfer
supernat
along
previou
spin
tube
centrifug
g
rpm
min
remov
remain
debri
sonic
supernat
min
water
bath
sonic
distribut
two
tube
underlay
equal
volum
w
v
sucros
mm
ph
fill
tube
centrifug
tube
rpm
g
rotor
min
centrifug
remov
supernat
treat
bleach
discard
resuspend
pellet
ml
mm
ph
per
tube
easi
resuspend
sonic
necessari
combin
dispens
small
pl
aliquot
purifi
viru
store
usual
viru
purifi
protocol
yield
x
pfuml
aliquot
thaw
use
remaind
refrozen
use
twice
without
substanti
loss
titer
titer
viru
perform
infect
cell
typic
hela
bsci
variou
dilut
viru
determin
number
infecti
particl
per
millilit
count
number
plaqu
form
usual
use
hela
cell
plaqu
form
bsci
monolay
easier
distinguish
quantifi
protocol
titer
viru
basic
describ
select
vaccinia
recombin
section
c
howev
purifi
viru
requir
treatment
trypsin
prior
plaqu
also
agaros
overlay
necessari
sinc
viru
remain
cellassoci
thu
spread
readili
cultur
medium
agaros
overlay
contain
neutral
red
stain
andor
xgal
ad
cell
prior
count
plaqu
aid
visual
grow
cell
dish
nearli
confluent
usual
x
cellslwel
plate
day
titer
viru
thaw
aliquot
purifi
viru
dilut
serial
serumfre
dmem
includ
neg
control
viru
posit
control
purifi
vaccinia
viru
known
titer
dilut
concentr
design
give
plaqu
rins
cell
pb
add
serumfre
dmem
well
place
dish
incub
rock
everi
min
min
replac
inoculurn
rnl
complet
medium
day
aspir
medium
stain
cell
crystal
violet
ethanol
min
aspir
stain
allow
well
dri
count
plaqu
altern
well
overlaid
ml
agaros
contain
neutral
red
andor
xgal
overlay
procedur
describ
section
ii
c
count
plaqu
well
possibl
determin
titer
pfuml
base
dilut
viru
use
infect
cell
add
pl
dilut
viru
use
dilut
rang
lo
mention
introduct
rna
polymeras
method
vacciniamedi
express
quit
conveni
sinc
one
recombin
viru
need
addit
gene
express
clone
commonli
use
vector
pbluescript
howev
special
design
vector
contain
slightli
extend
version
promot
termin
sequenc
give
better
express
fig
high
level
express
vector
construct
contain
untransl
leader
region
encephalomyocard
viru
well
promot
termin
messag
produc
polymeras
ineffici
cap
vaccinia
cap
enzym
leader
region
encephalomyocard
viru
allow
capindepend
translat
elroy
stein
et
al
howev
increas
protein
express
obtain
system
may
practic
cell
biolog
studi
see
section
v
b
protocol
direct
indirect
method
express
essenti
except
addit
transfect
step
follow
infect
polymerasemedi
system
discuss
protocol
protein
express
togeth
section
addit
step
system
describ
appropri
place
wide
varieti
cell
line
use
express
protein
interest
chines
hamster
ovari
cho
cell
except
sinc
nonpermiss
vaccinia
infect
addit
polar
madindarbi
canin
kidney
mdck
cell
poorli
infect
examin
protein
express
use
metabol
label
imrnunoblot
immunofluoresc
cell
plate
day
infect
reach
confluenc
approxim
x
dish
larger
dish
may
use
applic
howev
express
usual
high
enough
requir
cell
rins
pb
infect
anoth
recombin
viru
viru
pfucel
dish
ad
ml
serumfre
dmem
per
dish
addit
viru
dish
return
incub
rock
everi
min
min
protein
interest
express
directli
recombin
viru
inoculum
replac
infect
ml
regular
growth
medium
contain
serum
step
omit
note
express
mediat
via
polymeras
infect
period
use
prepar
dna
transfect
transfect
perform
use
either
cation
lipid
calcium
phosphat
carrier
lipidmedi
transfect
pg
plasmid
dna
qiagenpurifi
work
best
miniprep
dna
also
use
ad
ml
serumfre
dmem
per
dish
cell
mix
lipofectac
gibcobrl
ad
side
tube
immedi
vortex
sec
lipofectin
gibcobrl
also
work
well
expens
mixtur
incub
ambient
temperatur
min
end
viral
infect
period
inoculum
replac
dnatransfectac
mixtur
calcium
phosphatemedi
transfect
precipit
contain
pg
purifi
plasmid
dna
encod
foreign
gene
behind
promot
prepar
ad
cell
exactli
describ
section
ii
b
longer
use
ca
po
method
transfect
much
less
reproduc
cation
lipid
method
transfect
dish
return
incub
incub
time
vari
depend
type
analysi
perform
see
next
section
metabol
label
initi
earli
hr
postinfect
cell
starv
rnin
medium
lack
amino
acid
use
radiolabel
cell
short
puls
label
use
high
express
level
puls
period
short
rnin
pciml
methionin
typic
give
overnight
exposur
appropri
pulsechas
period
cell
lyse
nonion
deterg
use
deterg
solut
contain
mm
ph
mm
edta
deoxychol
tiu
aprotinidml
typic
lysi
buffer
contain
triton
trisbuff
salin
proteas
inhibitor
spin
nuclei
debri
rnin
microfug
protein
interest
immunoprecipit
electrophores
desir
solubil
immunoprecipit
condit
must
determin
empir
antibodyantigen
combin
typic
lyse
cell
dish
ml
deterg
solut
describ
earlier
polyclon
antibodi
mani
monoclon
antibodi
seem
work
well
mixtur
min
ice
lysat
transfer
microfug
tube
nuclei
debri
remov
spin
min
supernat
transfer
fresh
tube
sd
ad
final
concentr
sd
help
reduc
background
bind
immunoprecipit
monoclon
antibodi
gener
omit
sd
antibodi
ad
tube
rotat
hr
overnight
use
fix
staphylococcu
aureu
cell
calbiochem
san
diego
ca
collect
antigenantibodi
complex
min
protein
asepharos
also
use
immunoprecipit
wash
time
ripa
buffer
nacl
mm
ph
deoxychol
sd
sampl
usual
elut
directli
sd
sampl
buffer
contain
reduc
agent
electrophores
sdspolyacrylamid
gel
altern
sampl
elut
treat
endoor
exoglycosidas
analyz
carbohydr
modif
protocol
digest
endoglycosidas
h
given
legend
fig
immunoblot
express
protein
detect
immunoblot
advisabi
wait
hr
postinfect
lyse
cell
allow
chemic
amount
protein
accumul
cell
infect
transfect
necessari
describ
alreadi
appropri
incub
time
medium
remov
trichloroacet
acid
precipit
protein
secret
dish
rins
cold
pb
remov
last
trace
pb
cell
lyse
dish
ad
laemmli
sampl
buffer
contain
reduc
agent
swirl
pipet
tip
draw
lysat
togeth
dna
lyse
nuclei
make
viscou
solut
sampl
transfer
microfug
tube
heat
min
longer
requir
fulli
shear
dna
load
onto
sdspolyacrylamid
gel
electrophoresi
protein
transfer
nitrocellulos
suitabl
membran
incub
primari
antibodi
protein
detect
use
colorimetr
chemiluminesc
method
incub
appropri
conjug
second
antibodi
exampl
immunoblot
use
follow
time
cours
protein
express
shown
fig
signific
level
express
protein
usual
detect
immunofluoresc
stain
hr
infect
depend
cell
type
use
subcellular
local
protein
protein
becom
concentr
subcellular
compart
eg
nuclear
golgi
lysosom
protein
may
detect
shorter
time
infect
protein
diffus
local
eg
plasma
membran
cytoplasm
protein
long
time
infect
hr
local
immunofluoresc
becom
fig
time
cours
vsv
g
protein
express
express
bhk
cell
infect
transfect
describ
pg
per
dish
parg
encod
g
protein
vesicular
stomat
viru
vsv
time
point
individu
dish
rins
pb
solubil
pl
laemmli
sampl
buffer
contain
pmercaptoethanol
sampl
heat
c
min
prior
electrophoresi
polyacrylamid
gel
protein
transfer
nitrocellulos
incub
overnight
antivsv
polyclon
antibodi
block
trisbuff
salin
contain
nonfat
dri
milk
primari
antibodi
detect
horseradishconjug
goat
antirabbit
igg
enhanc
chemiluminesc
ecl
amersham
arlington
height
increasingli
difficult
cell
becom
round
chang
cell
shape
make
difficult
focu
certain
intracellular
compart
long
infect
time
must
use
confoc
microscopi
recommend
protein
detect
immunofluoresc
cell
plate
glass
cover
slip
dish
day
infect
mani
cell
type
plain
cover
slip
use
steril
autoclav
howev
cell
attach
better
glass
pretreat
acid
wash
coat
polylysin
mgml
extracellular
matrix
compon
fibronectin
pgml
vaccinia
infect
subsequ
dna
transfect
perform
describ
section
desir
incub
period
cell
fix
formaldehyd
methanolaceton
methanolaceton
fixat
may
requir
compon
cytoskeleton
analyz
usual
consist
min
methanol
c
follow
sec
min
aceton
permeabil
requir
note
find
formaldehyd
fixat
work
well
antibodi
use
see
subsequ
discuss
method
analysi
optim
antibodi
dilut
paramet
determin
protein
guidelin
polyclon
sera
usual
dilut
monoclon
antibodi
tissu
cultur
supernat
use
straight
dilut
affinitypurifi
antibodi
purifi
igg
use
pgl
ml
commerci
prepar
secondari
antibodi
conjug
fluorescein
rhodamin
texa
red
avail
mani
supplier
excel
success
affinitypurifi
prepar
jackson
immunoresearch
west
grove
pa
protocol
includ
fixat
paraformaldehyd
pb
fix
quench
use
pbsgli
pb
glycin
intracellular
epitop
label
cell
permeabil
min
triton
pbsgli
rins
pbsgli
typic
add
rnin
incub
block
solut
ovalbumin
pbsgli
j
remov
aggreg
centrifug
antibodi
microfug
sec
primari
secondari
antibodi
dilut
block
solut
throughout
stain
procedur
import
cover
slip
never
dri
cover
slip
lift
forcep
corner
touch
kimwipeb
drain
much
liquid
possibl
slip
place
cellsid
onto
drop
pl
primari
antibodi
sheet
parafilm
incub
min
room
temperatur
min
room
temperatur
cover
slip
return
cellsid
dish
wash
min
sever
chang
pbsgli
incub
pl
fluorochromeconjug
secondari
antibodi
describ
min
dark
wash
pbsgli
min
back
cover
slip
gentli
wipe
invert
onto
small
drop
glycerol
microscop
slide
use
glycerol
contain
mm
npropyl
gallat
reduc
photobleach
glycerol
contain
phenylaminediamin
commerci
mount
medium
also
use
excess
mount
medium
aspir
cover
slip
may
seal
slide
nail
polish
view
microscop
equip
epifluoresc
appropri
barrier
filter
exampl
indirect
immunofluoresc
detect
protein
express
use
polymerasevaccinia
hybrid
system
shown
fig
chapter
discuss
prepar
use
recombin
vaccinia
virus
express
protein
mammalian
cell
method
offer
mani
advantag
express
system
express
protein
see
howev
limit
method
taken
account
choos
techniqu
vaccinia
virusmedi
express
rapid
effici
experi
perform
day
furthermor
cell
dish
infect
result
much
higher
effici
express
transient
express
system
vaccinia
wide
host
rang
mammalian
tissu
cultur
cell
line
suscept
infect
one
except
cho
cell
line
suscept
infect
viru
howev
cowpox
viru
infect
cho
cell
gene
allow
infect
recent
character
spehner
et
al
possibl
construct
vacciniaviru
recombin
contain
cowpox
gene
allow
product
infect
cho
cell
high
effici
express
coexpress
two
protein
simpl
use
techniqu
express
level
protein
vari
amount
viru
dna
use
depend
method
express
eg
zagoura
et
ul
express
system
oper
cytoplasm
use
express
gene
rna
virus
contain
cryptic
splice
site
use
cdna
insert
vector
must
transcrib
nucleu
macham
rose
infect
recombin
vaccinia
virus
result
high
express
level
cell
dish
soon
infect
method
therefor
ideal
subcellular
local
express
protein
immunoelectron
microscopi
macham
et
krijns
locker
et
earli
time
postinfect
hr
analyz
avoid
complic
viral
cytopath
effect
local
protein
express
via
polymeras
hybrid
system
difficult
sinc
celluiar
morpholog
alter
dna
carrier
use
transfect
especi
cation
lipid
vaccinia
virusmedi
express
use
product
biolog
activ
protein
protein
express
mammalian
cell
line
glycosyl
posttransl
modif
may
necessari
activ
preserv
advantag
specif
polymeras
hybrid
express
system
use
screen
rapidli
express
newli
clone
cdna
mutant
protein
gener
sitedirect
mutagenesi
vector
use
mutagenesi
sequenc
uitro
transcriptiontransl
vaccinia
virusmedi
express
addit
high
percentag
cell
transfect
dna
need
reach
cytoplasm
nucleu
express
seriou
disadvantag
vaccinia
viru
system
express
level
may
high
overwhelm
cellular
translat
transloc
machineri
result
decreas
effici
membran
transloc
posttransl
modif
transport
secretori
pathway
high
express
level
newli
synthes
protein
enter
secretori
pathway
may
accumul
er
observ
reduc
rate
transport
vesicular
stomat
viru
vsv
g
protein
cell
surfac
compar
vsvinfect
cell
protein
express
hybrid
system
fig
wherea
vsv
g
becom
resist
endoglycosidas
h
move
golgi
complex
halftim
min
vsvinfect
hela
cell
halftim
consider
slower
min
transfect
cell
differ
transport
kinet
may
less
dramat
cell
type
cytopath
effect
vaccinia
infect
problem
certain
type
analysi
exampl
earli
effect
infect
round
cell
probabl
due
chang
induc
cytoskeleton
make
convent
immunofluoresc
difficult
interpret
fig
addit
host
cell
protein
synthesi
inhibit
infect
cell
vaccinia
encod
homolog
cellular
protein
includ
superoxid
dismutas
epiderm
growth
factor
profilin
goebel
et
al
express
could
affect
cell
morpholog
behavior
unpredict
way
although
viral
dna
replic
earli
assembl
step
block
treat
infect
cell
hydroxyurea
rifampicin
respect
earli
cytopath
effect
cell
round
unfortun
prevent
recombin
vaccinia
virus
difficult
timeconsum
produc
inhibit
transcript
earli
promot
nt
sequenc
gene
interest
must
mutagen
prior
subclon
recombin
vector
even
recombin
virus
imposs
produc
perhap
express
foreign
protein
incompat
vaccinia
replic
assembl
final
consider
prior
use
vaccinia
virusmedi
protein
express
system
safeti
laboratori
worker
institut
guidelin
use
vaccinia
viru
recombin
must
follow
institut
requir
vaccin
smallpox
vaccinia
user
everi
year
recommend
nih
cdc
howev
see
grist
wenzel
cell
hela
cell
grown
dish
infect
follow
lipofectacemedi
transfect
pg
parg
per
dish
describ
section
iv
b
vsv
pfuicel
hr
postinfect
cell
rins
pb
starv
min
methioninefre
dmem
pulselabel
min
pc
uioolabel
mix
amersham
mi
methioninefre
dmem
per
dish
cell
chase
growth
medium
indic
chase
time
individu
dish
lyse
deterg
solut
immunoprecipit
use
polyclon
antivsv
antibodi
describ
section
sampl
elut
pi
tri
ph
sd
min
eluent
divid
half
either
citrat
ph
amount
buffer
contain
mu
endoglycosidas
h
endo
h
ad
overnight
incub
concentr
laemmli
sampl
buffer
ad
sampl
heat
min
electrophores
laemmli
sdspolyacrylamid
gel
percentag
vsv
g
protein
resist
endo
h
time
point
quantit
densitometr
scan
fluorograph
gel
nettleman
restrict
also
appli
avail
virusonli
laminar
flow
hood
recommend
avoid
accident
infect
cell
line
routin
tissu
cultur
although
problem
accident
infect
ultraviolet
light
left
adequ
time
follow
work
infect
cell
small
aliquot
vaccinia
viru
wildtyp
recombin
vector
produc
recombin
virus
polymerasemedi
express
obtain
write
dr
bernard
moss
laboratori
viral
diseas
niaid
nih
rockvil
pike
bldg
bethesda
md
new
user
must
demonstr
facil
meet
biosafeti
requir
follow
institut
guidelin
regard
vaccin
addit
materi
transfer
agreement
nih
must
complet
sign
institut
prior
receipt
stock
